Clinical Trial Update: To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study evaluating Hemay005 tablets in patients with renal impairment has completed, with psoriasis listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Psoriasis | Phase 1 | Status: COMPLETED